Thames Ventures VCT 2 plc (TV2H) Ord GBP0.001 Healthcare
No change
- Add to watchlist
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
36.50p
n/a
54.50p
40.65
36.50p
n/a
36.50p
-10.21%
0.00p (0.00%) Previous:
0.00p
n/a
0.68%
GBX
Price
-
Net Asset Value (NAV)
Performance
Not available for this stock.
Trust Basics
| Benchmark: | Numis Smaller Companies TR GBP |
|---|---|
| Annual management charge: | n/a |
| Performance fee: | Yes |
| Ongoing charge: | 2.50% |
| Dividend yield: | 0.68% |
| Dividend frequency: | Annually |
| Total assets: | £10m |
| Gross gearing: | 0% |
| Market capitalisation:Market cap.: | £9m |
| Shares in issue: | 90.68 million |
| Legal structure | Closed Ended Investment Company |
| Domicile: | United Kingdom |
| ISIN | GB00BDHF5D62 |
Recent dividends paid or declared by Thames Ventures VCT 2 plc:
| Type | Ex-div date | Payment date | Amount |
|---|---|---|---|
| Final * | 03/10/2024 | 18/10/2024 | 0.25p |
| Final | 31/08/2023 | 29/09/2023 | 1.25p |
| Final | 01/09/2022 | 30/09/2022 | 3.50p |
| Final | 02/09/2021 | 24/09/2021 | 2.75p |
| Interim | 03/09/2020 | 25/09/2020 | 2.50p |
* Dividend has not yet been paid but has been declared by Thames Ventures VCT 2 plc.
This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.
Full dividend historyFive years' total annual Thames Ventures VCT 2 plc dividends:
| Financial year end |
Dividend yield |
Dividend cover |
Total dividend paid |
|---|---|---|---|
| 31/03/2024 | 0.50% | -5.60 | 0.25p |
| 31/03/2023 | 1.90% | -1.12 | 1.25p |
| 31/03/2022 | 4.20% | -0.46 | 3.50p |
| 31/03/2021 | 4.00% | -0.22 | 2.75p |
| 31/03/2020 | 4.20% | -0.52 | 2.50p |
All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.
Full dividend historyReady to invest?
Important Documents
Objective
NET ASSET VALUE (NAV)
| Estimated NAV: | 40.65p |
|---|---|
| Latest actual NAV: | 40.90p |
| Latest actual NAV date: | 30 June 2024 |
| Premium/Discount: | -10.21% |
| 12m average Premium/Discount: | -10.44% |
| NAV frequency: | Quarterly |
| Security | Weight |
|---|---|
| Arecor Therapeutics plc ORD GBP0.01 | 17.89% |
| ADAPTIX LIMITED | 11.39% |
| OPEN BIONICS LIMITED | 10.08% |
| Fvrvs Limited (T/A Fundamental Vr) | 9.64% |
| Ge Nin Code Plc | 6.69% |
| Congenica Limited | 5.35% |
| Cambridge Respiratory Innovations Limited | 4.95% |
| Closed Loop Medicine Limited | 4.02% |
| Dia Imaging Analysis Limited | 3.51% |
| The Electrospinning Company Limited | 3.36% |
Top 10 sectors currently unavailable.
| Country | Weight |
|---|---|
| United Kingdom | 20.07% |
Key Dates
| Launch date: | 21 February 2017 |
|---|---|
| Financial year end: | March |
| Next AGM: | September 2025 |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.